https://www.selleckchem.com/pr....oducts/cftrinh-172.h
Most gastrointestinal stromal tumors (GIST) harbor a mutation in or platelet-derived growth factor receptor alfa ( . Although genotyping is a useful predictive marker of tyrosine kinase inhibitors, whether it can predict prognosis remains controversial. Data on 402 patients with GIST who underwent macroscopically complete surgery and received no neoadjuvant/adjuvant therapy were selected from a prospective GIST database at the three, participating hospitals. The types and locations of and mutations were analyzed by direct sequencing
Like
Comment
Share
